Immune checkpoint inhibitor-related acral vasculitis

Commentary on « Ipilimumab induced vasculitis » by Padda A. et al., J Immunother Cancer. 2018;6:12. The authors diagnosed a small vessel vasculitis following treatment with anti-CTLA-4 (ipilimumab) for a resected stage III B/C melanoma. We report a similar case of acral vasculitis occurring with a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Comont, Thibault, Sibaud, Vincent, Mourey, Loïc, Cougoul, Pierre, Beyne-Rauzy, Odile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240222/
https://www.ncbi.nlm.nih.gov/pubmed/30446009
http://dx.doi.org/10.1186/s40425-018-0443-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240222/
https://www.ncbi.nlm.nih.gov/pubmed/30446009
http://dx.doi.org/10.1186/s40425-018-0443-6

Ejemplares similares